The role of cardiac CT during the COVID-19 pandemic

    Authors

    Abstract

    Main role of coronary computed tomography angiography (CCTA) is to rule out obstruction in patients with suspected coronary artery disease (but no ST-elevation myocardial infarction), and to alleviate invasive cardiology of unnecessary diagnostic procedures. This is especially useful in situation of COVID-19 pandemic, since CCTA can be performed in outpatient setting, with very short times of personnel to patient exposure. (1) In 2020 we had 1393 patients on CCTA (a 30% increase from 2019), and in 69% we excluded obstructive coronary artery disease. We believe this shows that CCTA as first line strategy can, when appropriate, relieve invasive cardiology, and comparatively reduce COVID-19 transmission channels.

    Keywords

    coronary computed tomography angiography, COVID-19, invasive cardiology

    DOI

    https://doi.org/10.15836/ccar2021.53

    Literature

    1. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020 January 14;41(3):407–77. https://doi.org/10.1093/eurheartj/ehz425
    Cardiologia Croatica
    Back to search

    The role of cardiac CT during the COVID-19 pandemic

    Extended Abstract
    Issue1-2
    Published
    Pages53
    PDF via DOIhttps://doi.org/10.15836/ccar2021.53
    coronary computed tomography angiography
    COVID-19
    invasive cardiology

    Authors

    Mladen Jukić*ORCIDSpecial Hospital AGRAM, Zagreb, Croatia

    *Correspondence email: mladen.jukic@agram-bolnica.hr

    Abstract

    Main role of coronary computed tomography angiography (CCTA) is to rule out obstruction in patients with suspected coronary artery disease (but no ST-elevation myocardial infarction), and to alleviate invasive cardiology of unnecessary diagnostic procedures. This is especially useful in situation of COVID-19 pandemic, since CCTA can be performed in outpatient setting, with very short times of personnel to patient exposure. (1) In 2020 we had 1393 patients on CCTA (a 30% increase from 2019), and in 69% we excluded obstructive coronary artery disease. We believe this shows that CCTA as first line strategy can, when appropriate, relieve invasive cardiology, and comparatively reduce COVID-19 transmission channels.

    Literature

    1. 1.
      Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020 January 14;41(3):407–77.DOI